IMMUNE-RESPONSE MODULATING THERAPY IN CHILDREN WITH RECURRENT RESPIRATORY INFECTIONS

Abstract

The article is devoted to one of the most «problematic» aspects of Pediatrics — use of immune-response modulating drugs. Complexity is due as to the abundance of similar agents on the pharmacological market also to the evident absence of the proved efficacy and safety of most of them. The authors focused their attention on the category of patients, to whom these drugs were most commonly prescribed — i. e. children with recurrent acute respiratory infections. Along with the classification the characteristics of the different groups of immune-response modulating drugs are presented.
Key words: children with recurrent acute respiratory infections, acute respiratory infections, immune-response modulating therapy, ribosomal-proteoglican complex.
(Pediatric pharmacology. — 2011; 8 (6): 108–113).